Literature DB >> 16675464

The peptidylprolyl cis/trans-isomerase Pin1 modulates stress-induced dephosphorylation of Tau in neurons. Implication in a pathological mechanism related to Alzheimer disease.

Marie-Christine Galas1, Pierre Dourlen, Séverine Bégard, Kunié Ando, David Blum, Malika Hamdane, Luc Buée.   

Abstract

Deregulation of Tau phosphorylation is a key question in Alzheimer disease pathogenesis. Recently, Pin1, a peptidylprolyl cis/trans-isomerase, was proposed to be a new modulator in Tau phosphorylation in Alzheimer disease. In vitro, Pin1 was reported to present a high affinity for both Thr(P)-231, a crucial site for microtubule binding, and Thr(P)-212. In fact, Pin1 may facilitate Thr(P)-231 dephosphorylation by protein phosphatase 2A through trans isomerization of the Thr(P)-Pro peptide bound. However, whether Pin1 binding to Tau leads to isomerization of a single site or of multiple Ser/Thr(P)-Pro sites in vivo is still unknown. In the present study, Pin1 involvement was investigated in stress-induced Tau dephosphorylation with protein phosphatase 2A activation. Both oxidative (H2O2) and heat stresses induced hypophosphorylation of a large set of phospho-Tau epitopes in primary cortical cultures. In both cases, juglone, a Pin1 pharmacological inhibitor, partially prevented dephosphorylation of Tau at Thr-231 among a set of phosphoepitopes tested. Moreover, Pin1 is physiologically found in neurons and partially co-localized with Tau. Furthermore, in Pin1-deficient neuronal primary cultures, H2O2 stress-induced Tau dephosphorylation at Thr(P)-231 was significantly lower than in wild type neurons. Finally, Pin1 transfection in Pin1-deficient neuronal cell cultures allowed for rescuing the effect of H2O2 stress-induced Tau dephosphorylation, whereas a Pin1 catalytic mutant did not. This is the first demonstration of an in situ Pin1 involvement in a differential Tau dephosphorylation on the full-length multiphosphorylated substrate.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16675464     DOI: 10.1074/jbc.M601849200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  32 in total

Review 1.  FKBP51 and FKBP52 in signaling and disease.

Authors:  Cheryl L Storer; Chad A Dickey; Mario D Galigniana; Theo Rein; Marc B Cox
Journal:  Trends Endocrinol Metab       Date:  2011-08-31       Impact factor: 12.015

2.  Nuclear tau, a key player in neuronal DNA protection.

Authors:  Audrey Sultan; Fabrice Nesslany; Marie Violet; Séverine Bégard; Anne Loyens; Smail Talahari; Zeyni Mansuroglu; Daniel Marzin; Nicolas Sergeant; Sandrine Humez; Morvane Colin; Eliette Bonnefoy; Luc Buée; Marie-Christine Galas
Journal:  J Biol Chem       Date:  2010-12-03       Impact factor: 5.157

3.  γ-Aminobutyric acid type A (GABAA) receptor activation modulates tau phosphorylation.

Authors:  Niko-Petteri Nykänen; Kai Kysenius; Prasanna Sakha; Päivi Tammela; Henri J Huttunen
Journal:  J Biol Chem       Date:  2012-01-10       Impact factor: 5.157

Review 4.  Bending tau into shape: the emerging role of peptidyl-prolyl isomerases in tauopathies.

Authors:  John Koren; Umesh K Jinwal; Zachary Davey; Janine Kiray; Karthik Arulselvam; Chad A Dickey
Journal:  Mol Neurobiol       Date:  2011-04-28       Impact factor: 5.590

5.  Pin1 mediates Aβ42-induced dendritic spine loss.

Authors:  Nancy R Stallings; Melissa A O'Neal; Jie Hu; Ege T Kavalali; Ilya Bezprozvanny; James S Malter
Journal:  Sci Signal       Date:  2018-03-20       Impact factor: 8.192

Review 6.  Chronic traumatic encephalopathy-integration of canonical traumatic brain injury secondary injury mechanisms with tau pathology.

Authors:  Jacqueline R Kulbe; Edward D Hall
Journal:  Prog Neurobiol       Date:  2017-08-26       Impact factor: 11.685

7.  Effect of Pin1 or microtubule binding on dephosphorylation of FTDP-17 mutant Tau.

Authors:  Kensuke Yotsumoto; Taro Saito; Akiko Asada; Takayuki Oikawa; Taeko Kimura; Chiyoko Uchida; Koichi Ishiguro; Takafumi Uchida; Masato Hasegawa; Shin-ichi Hisanaga
Journal:  J Biol Chem       Date:  2009-04-28       Impact factor: 5.157

8.  Peptidyl-prolyl isomerase Pin1 markedly enhances the oncogenic activity of the rel proteins in the nuclear factor-kappaB family.

Authors:  Gaofeng Fan; Yongjun Fan; Nupur Gupta; Isao Matsuura; Fang Liu; Xiao Zhen Zhou; Kun Ping Lu; Céline Gélinas
Journal:  Cancer Res       Date:  2009-05-19       Impact factor: 12.701

9.  Inhibition of Pin1 reduces glutamate-induced perikaryal accumulation of phosphorylated neurofilament-H in neurons.

Authors:  Sashi Kesavapany; Vyomesh Patel; Ya-Li Zheng; Tej K Pareek; Mia Bjelogrlic; Wayne Albers; Niranjana Amin; Howard Jaffe; J Silvio Gutkind; Michael J Strong; Philip Grant; Harish C Pant
Journal:  Mol Biol Cell       Date:  2007-07-11       Impact factor: 4.138

10.  The Pin 1 inhibitor juglone attenuates kidney fibrogenesis via Pin 1-independent mechanisms in the unilateral ureteral occlusion model.

Authors:  Shannon Reese; Aparna Vidyasagar; Lynn Jacobson; Zeki Acun; Stephane Esnault; Debra Hullett; James S Malter; Arjang Djamali
Journal:  Fibrogenesis Tissue Repair       Date:  2010-01-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.